Pura Vida Investments’s CureVac CVAC Stock Holding History

Pura Vida Investments’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-76,700	Closed	-$4.19M	–	252
2021 Q3	$4.19M	Sell	76,700 -50,000	-39%	-$3.01M	0.13%	157
2021 Q2	$9.31M	Buy	+126,700	New	+$12.7M	0.29%	79

Other funds holding CVAC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Pura Vida Investments's CVAC Position: Q1 2023 in Review

Pura Vida Investments sold out of CureVac (CVAC) in Q1 2023, closing a stake of 128,245 shares — an estimated $774K sold.

Pura Vida Investments first reported a position in CVAC in Q4 2022 and held it in 1 quarter. The position peaked at $774K in Q4 2022. 82 funds tracked by Wall St. Rank hold CVAC as of Q1 2023.

Pura Vida Investments reported no remaining CureVac position as of Q1 2023 after selling out during the quarter.
Pura Vida Investments sold 128,245 CureVac shares in Q1 2023, an estimated $774K.
Pura Vida Investments first reported a position in CureVac in Q4 2022 and held it in 1 quarter.
Pura Vida Investments's CureVac position peaked at $774K in Q4 2022.
82 funds tracked by Wall St. Rank held CureVac as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.